SUREMAB
LIVE

Serial Number

98332384

Owner

KBI Biopharma, Inc.

Attorney

F. Michael Sajovec

First Use Date

Jul 18, 2023

Filing Date

Dec 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SUREMAB Trademark

Serial Number: 98332384 • Registration: 7570798

SUREMAB is a trademark filed by KBI Biopharma, Inc. on December 27, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

KBI Biopharma, Inc. (9 trademarks)

1101 Hamlin Road
Durham, NC 27704

Entity Type: 03

Trademark Details

Filing Date

December 27, 2023

Registration Date

November 19, 2024

First Use Anywhere

July 18, 2023

First Use in Commerce

July 18, 2023

Published for Opposition

September 3, 2024

Goods & Services

Biotechnology research and development services for others, namely, mammalian cell line development, monoclonal antibody development, genome sequencing, genome mapping, genome and nucleic acid analysis, genome amplification, genome scanning, and high performance computing services for genome sequencing

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 19, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 19, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 14, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 26, 2024 CNSA
ASSIGNED TO EXAMINER
Jul 26, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 10, 2024 NWOS
NEW APPLICATION ENTERED
Dec 27, 2023 NWAP